Advertisement

Topics

Companies Related to "Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study" [Most Relevant Company Matches] - Page: 5 RSS

09:37 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study" found in our extensive corporate database of over 50,000 company records.

Showing "Antigonadotropin Leuprolide Alzheimer Disease Drug INvestigation ALADDIN Study" Companies 101–125 of 6,100+

Relevant

SNBL USA, Ltd.

Headquartered in Everett, WA, SNBL USA, Ltd. offers a unique range of safety assessment services to support the drug development process. Managed and operated by a team world renowned for its wide-ranging NHP experience and expertise, we offer programs ranging from regulatory toxicology to customized study designs and disease models. Our specialized capabi...


Alzheimer’s Australia

Dr Tanya Petrovich, Business Development Manager, Alzheimer’s Australia Vic;

Neurobiological Technologies

Neurobiological Technologies, Inc. (NTI) (NASDAQ: NTII) is a biotechnology company engaged in the business of acquiring and developing central nervous system (CNS) related drug candidates. The company is focused on therapies for neurological conditions that occur in connection with dementia, Alzheimer's disease, ischemic stroke, neuropathic pain, and brain cancer. The company employs a strategy ...


American Heartworm Society

The mission of the American Heartworm Society is to lead the veterinary profession and the public in the understanding of heartworm disease. Founded during the Heartworm Symposium of 1974. The American Heartworm Society aims to further scientific progress in the study of heartworm disease, inform the membership of new developments and encourage and help pr...

Zosano Pharma Corporation

Zosano Pharma Corporation is a clinical stage biopharmaceutical company focused on providing administration of therapeutics to patients using its intracutaneous delivery system, which consists of titanium microneedles coated with drug that can enable rapid systemic administration to patients. The company’s lead product candidate is QtryptaTM (M207), w...

United Neuroscience, Inc.

United Neuroscience (UNS) is a clinical-stage biotech company dedicated to the development of first-in-class, disease-modifying therapeutics for Alzheimer’s disease and other neurodegenerative disorders. UNS was founded to address the social and economic burden of neurodegenerative proteinopathies and seeks to rapidly advance candidates into and through ...

Humanetics Corporation

Humanetics is a privately-held specialty pharmaceutical company headquartered in Minneapolis, Minnesota. The company focuses on the rapid discovery, development and commercialization of new drug candidates for the prevention and treatment of diseases in categories with urgent and unmet needs. Humanetics has proprietary compounds in clinical and pre-clinica...

KARD Scientific

KARD scientific is the reliable resource for all your in vivo efficacy studies in drug discovery and development. For high quality, efficiency and cost effective services in cancer, neurological, inflammation, arthritis and other disease models. We can assist you in study design and methods for screening. We optimize the schedule, time points, routes, and combination studies, while keeping cl...

MedAvante, Inc.

MedAvante is the premier global provider of centralized expert psychiatric rating and monitoring services to the pharmaceutical, biotechnology and medical device industries. Our flagship service, Remote Centralized Ratings are real-time assessments, either by telephone or videoconference, of subjects in global drug trials. Centralizing the assessors and blinding them to study protocols, results in...

Prana Biotechnology

Prana Biotechnology has developed a proprietary library of class-leading chemical compounds. This library is combined with a drug development program to explore novel therapeutics in multiple disease indications. The scientific focus of the company is upon neurological diseases, particularly Alzheimer‘s, Parkinson‘s and Huntington‘s diseases. The company listed on the Australian Stock Excha...

Aranesp

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...

Neurotech Pharmaceutical Inc

Neurotech Pharmaceutical Inc. is a core biotechnology company in South Korea , established in 1998.Neurotech seeks to discover, develop, and commercialize major pharmaceutical products to cure brain related diseases, such as stroke, Parkinson ' s disease, Alzheimer ' s disease, spinal cord injury, and glaucoma. Our business strategy is to understand mechanisms of degenerative and regenerative neur...

The Alzheimer’s Drug Discovery Foundation (ADDF) and the Foundation for Mitochondrial Medicine (FMM)

ADx Healthcare

ADx Healthcare provides laboratory test solutions and healthcare education related to Alzheimer’s disease. The company is headquartered in Bellingham, WA.

DiaGenic ASA & Ferrer inCode

DiaGenic is an innovative Norwegian biotechnology company that seeks to create value for patients, partners, and investors by developing new and more patient friendly methods for early detection of diseases. DiaGenic is currently a world leader in analyzing gene expression signatures related to disease in easily available clinical samples such as periphera...

Gliatech Incorporated

Gliatech is engaged in the research, development and commercialization of ADCON, a family of proprietary, resorbable, carbohydrate polymer medical devices designed to inhibit surgical scarring and adhesions. In addition to the ADCON family of medical devices, the Company is pursuing the development of small molecule drug candidates for the treatment of several central nervous system disorders, inc...

Elan Corporation, plc

Elan Corporation, plc is a neuroscience-based biotechnology company focused on discovering and developing advanced therapies in neurodegeneration and autoimmune diseases, and realizing the potential of its scientific discoveries to benefit patients and shareholders. The company has two business units: BioNeurology, focused on Alzheimer’s and Parkinson...

Cold Genesys Inc.

Cold Genesys, Inc. is a clinical-stage immuno-oncology company focused on the development of oncolytic immunotherapies to combat cancer. In 2010, Cold Genesys acquired exclusive worldwide rights to develop CG0070 from BioSante Pharmaceuticals. CG0070 is currently under investigation in a Phase II, single-arm, open-label, pivotal study (BOND II) for patient...

Opsona Therapeutics Ltd.

Opsona is a leading immunology drug development company, focused on novel therapeutic approaches to key targets of the innate immune system associated with a wide range of major human diseases, including autoimmune and inflammatory diseases, solid organ transplantation, cancer, diabetes, Alzheimer's disease and others. The company was founded in 2004 by...

Oncology Services India

Oncology Services (OS) is a leading internationally operating CRO with unmatched expertise and extensive experience in oncology drug development and study management. OS provides end to end solutions for drug development including services of Phase I to IV, regulatory affairs, consulting for drug development, medical writing, Data management and statistics, Quality assurance and pharmacovigilance.

Proclara Biosciences

Proclara Biosciences is a biotechnology company advancing product candidates developed based on proprietary GAIM technology, which is capable of simultaneously targeting multiple toxic misfolded proteins. The broad applicability of the Proclara technology enables the company to target multiple protein misfolding diseases, including neurodegenerative diseas...

NephroGenex, Inc.

NephroGenex (www.nephrogenex.com) is a drug development company focusing on kidney disease. More than 20 million Americans have some form of chronic kidney disease, and over 400,000 in the US have end stage renal disease requiring dialysis, making renal disease one of the costliest illnesses to treat. The Company is developing Pyridorin(TM) (pyridoxamine dihydrochloride) as a treatment to slow t...

NeuroVision Imaging Inc.

NeuroVision (www.neurovision.com) was formed in 2010 and is headquartered in Sacramento, California. The company is developing digital imaging and diagnostic solutions for identifying retinal pathology related to Alzheimer’s Disease (AD). In a study published in NeuroImage by members of NVI’s founding team, under the direction of Keith L. ...

PreScience Labs, LLC

PreScience is a developmental stage bio-pharmaceutical company focused on the development of anti-cancer drugs. It has successfully completed preclinical mechanistic, in vitro and animal testing using intra-arterial delivery of its proprietary drug PSL-001. The FDA approved immediate enrollment of a Phase I, dose-escalating study, which PreScience intends ...

Texas Neurology, P.A.

Welcome to Texas Neurology Our Mission: "To serve our patients, physicians, colleagues and students by providing the highest quality of neurological care, consultative services and educational opportunities." Texas Neurology is committed to our patients by providing excellence in neurological care. Our doctors work closely with referring physicians to diagnose and treat disorders of the nervous sy...


More From BioPortfolio on "Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks